Emergent BioSolutions: Focus on Mpox and the Opioid Crisis
![](https://tradertimes.com/files/2025/02/Shu-Nasenspray-220250210-2486109699-1140x440.jpg)
Reading Time: 2 minutes
Emergent BioSolutions is a US-based biopharma company that specializes in the development and production of vaccines, antitoxins, and biodefense products. Biodefense encompasses measures to prevent, detect, and combat biological threats, such as bioterrorism attacks or disease outbreaks. The company is particularly well-known for its anthrax vaccine, which is significant for the US military and national emergency preparedness. In addition to the biodefense sector, Emergent is also engaged in contract manufacturing for other biotech and pharmaceutical...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.